Score Breakdown
Offering Ability
46
Cash Runway
0
Float Risk
62
Warrant Exposure
40
Convertible Debt
40
Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
model est. 27%
🔄 Reverse Split
model est. 55%
• 50-day avg $0.05 below $1 exchange minimum
Market Data
Market Cap$4.12M
Shares Outstanding20.77M
Float5.06M
Cash$53.90M
Debt$31.47M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 200.0% shares (2026Q1 vs prior)
1 institutional holders · 74.3K shares
#1
BARCLAYS PLC
74.3K shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
No current FINRA short-interest record is available for this ticker.
Recent SEC Activity
xbrl
XBRL WARRANT
2025-03-31
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual LSBCF Dilution Snapshot
LakeShore Biopharma Co., Ltd (LSBCF) has a DilutionScore of 33/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for LSBCF: xbrl on 2025-03-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — MEDIUM Risk
Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles: